COMMUNIQUÉS West-GlobeNewswire

Tyme Announces Interim Phase II Safety and Efficacy Data for SM-88 in Prostate Cancer at 2018 ASCO Genitourinary Cancers Symposium

08/02/2018 - 16:00

92% of Patients Have Maintained Radiographic Progression-Free Survival at a Median of 12 Months Since Biochemical-Recurrence All Patients Have Reported Stable Cognitive and Sexual Function on SM-88 Treatment No Reported [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

08/02/2018 - 15:01

FIT Biotech Oy Company release February 8, 2018 at 04:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes approved by the Board on December [...]

Adamas Announces Publication of Amantadine Immediate Release Subgroup Analysis From EASE LID 2 Open-label Study in Movement Disorders Clinical Practice

08/02/2018 - 15:00

EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that subgroup analyses of Parkinson’s disease patients taking amantadine immediate release (IR) who were [...]

Syneos Health Names Lisa van Capelle Chief Human Resources Officer

08/02/2018 - 15:00

RALEIGH, N.C., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization, has announced the appointment of Lisa van Capelle as Chief Human [...]

Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines

08/02/2018 - 15:00

Partnership aims to develop drugs for neurodegenerative diseases Denali will draw on Lonza’s expertise in developing and manufacturing complex biologic molecules BASEL, Switzerland and SOUTH SAN FRANCISCO, Calif., Feb. [...]

Gemphire Announces Pricing of $22 Million Public Offering of Common Stock

08/02/2018 - 15:00

LIVONIA, Mich., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]

Novo Nordisk files annual report with the SEC

08/02/2018 - 14:44

Bagsværd, Denmark, 8 February 2018 - Novo Nordisk A/S has filed its Annual Report 2017 on Form 20-F for the financial year 2017 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of [...]

HempTech (HTCO), a Nuvus Company, Rolls Out Grow.Droid Enterprise Station – Expandable to Thousands of Plants – Perpetual Harvest Starting in 8 to 10 Weeks

08/02/2018 - 14:41

Saint Petersburg, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- HempTech Corp. (OTC PINK: HTCO), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the [...]

Abattis Completes Investment in CannaNUMUS Blockchain and Announces CannaNUMUS’s Achievement of a Significant Milestone

08/02/2018 - 14:37

VANCOUVER, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) announces that, further to its news release dated February 1, 2018, it has [...]

Ultragenyx to Present at Leerink Partners Global Healthcare Conference

08/02/2018 - 14:30

NOVATO, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

First Choice Healthcare Solutions’ Wholly-Owned Subsidiary Acquires Majority Ownership Interest in Crane Creek Surgery Center

08/02/2018 - 14:30

Management to Host Shareholder Update Conference Call to Discuss Crane Creek and Strategic Partnership in Further Detail on Thursday, February 8th at 11:00 a.m. ET MELBOURNE, Fla., Feb. 08, 2018 (GLOBE NEWSWIRE) -- [...]

Arbutus Consolidates HBV Business Around Warminster, PA Site

08/02/2018 - 14:30

VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today [...]

Anthera Pharmaceuticals to Participate in the BIO CEO & Investor Conference and SunTrust Robinson Humphrey’s 4th Annual Orphan Drug Day

08/02/2018 - 14:30

HAYWARD, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening [...]

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Developments on March 1, 2018

08/02/2018 - 14:30

CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

Tower One Continues to Build and Receive Additional Search Rings

08/02/2018 - 14:30

VANCOUVER, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces that tower demand in Argentina has remained [...]

Cellectar Biosciences to Present at the 2018 BIO CEO & Investor Conference

08/02/2018 - 14:15

MADISON, Wis., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]

Momenta Pharmaceuticals to Webcast Presentation at the LEERINK Partners 7th Annual Global Healthcare Conference

08/02/2018 - 14:00

CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it [...]

Genocea to Host Fourth Quarter and Year End 2017 Financial Results Conference Call & Webcast on February 15, 2018 at 9 a.m. ET

08/02/2018 - 14:00

CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that it will host a conference call and [...]

Zogenix to Participate in Leerink Partners 7th Annual Global Healthcare Conference

08/02/2018 - 14:00

EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]